Jong Hoon Kim

Clinical Assistant Professor

Yonsei University College of Medicine

South Korea

Research Interests

Explore related searches

Professors in South Korea Professors in Immunology Immunology professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Jong Hoon Kim is a Clinical Assistant Professor at Yonsei University College of Medicine in South Korea. His research focuses on autoimmune bullous diseases, particularly the efficacy and safety of treatments such as rituximab and omalizumab. He has contributed significantly to understanding the clinical features and burden of dermatological conditions, including palmoplantar pustulosis and pemphigus vulgaris.

Articles (13)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (3)

Kee Yang Chung

Professor

Yonsei University College of Medicine

SOUTH KOREA

View details

Jihee Kim

Yonsei University College of Medicine

SOUTH KOREA

View details

Byung Soo Kim

Professor

Pusan National University School of Medicine

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jong Hoon Kim

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Disease features, treatments, and burden of palmoplantar pustulosis in Korea: The EPPPIK study

Clinical relevance of circulating autoantigen-specific T-follicular regulatory cells in pemphigus vulgaris

Comparative study of efficacy and safety: Biosimilar rituximab versus originator rituximab in the treatment of pemphigus

Reply to “Regarding the risk factors of rituximab‐induced thrombocytopenia in patients with autoimmune bullous diseases”

Risk factors of rituximab‐induced thrombocytopenia in patients with autoimmune bullous diseases

Clinical effect of omalizumab as an adjuvant treatment to rituximab in patient with refractory bullous pemphigoid

Kaposi Sarcoma in a Patient with Bullous Pemphigoid Treated with Low-Dose Corticosteroids

CD5 Suppresses IL-15–Induced Proliferation of Human Memory CD8+ T Cells by Inhibiting mTOR Pathways

Clinical outcome and B‐cell kinetics in intercellular immunoglobulin A dermatosis treated with rituximab

Immunopathology and Immunotherapy of Inflammatory Skin Diseases

Mortality and clinical response of patients with bullous pemphigoid treated with rituximab

PTEN Promoter Hypermethylation Is Associated with Breslow Thickness in Acral Melanoma on the Heel, Forefoot, and Hallux

Personalized dosing of ixekizumab for psoriasis

Collaborators (3)

Kee Yang Chung

Jihee Kim

Byung Soo Kim

Make your next move.